Skip to main content


Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Figure 4 | Skeletal Muscle

Figure 4

From: Altered sodium channel-protein associations in critical illness myopathy

Figure 4

FGFs appear unlikely to contribute to altered sodium channel gating in CIM. ( A) FGF12 and 13 levels in muscle membrane samples from control and CIM muscle. As positive controls, tissues or expression vectors known to produce the protein of interest were used: for the pan-NaV 1.x Ab, skeletal muscle; for FGF13, a lysate of 293 cells transfected with an FGF13 expression vector; for FGF12, brain membranes. (B) FGF13 was expressed in both control and CIM muscle, such that the relative ratio of FGF13: sodium channel did not change in CIM. In contrast, FGF12B was expressed at low levels in control muscle, but increased in CIM muscle, such that the ratio of FGF12B: sodium channel significantly increased. Asterisk indicates P < 0.05. ( C) Cross-section of control and CIM medial gastrocnemius muscle stained for FGF12, dystrophin, and overlay reveals that most FGF12 staining is in myonuclei and nuclei of cells in the interstitial space.

Back to article page